Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Liver Diseases

  Free Subscription


28.09.2026

2 Am J Pathol
1 Biochem Biophys Res Commun
1 BMC Gastroenterol
1 Gastroenterology
1 Gastrointest Endosc
7 Gut
2 Hepatology
2 J Clin Oncol
3 J Gastroenterol Hepatol
2 J Hepatol
1 PLoS One
2 Transplantation


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Pathol

  1. HUAI Q, Li X, Wang H, Yin S, et al
    The Gut-Liver Axis in Metabolic Dysfunction-Associated Steatotic Liver Disease and Associated Hepatocellular Carcinoma: Pathogenesis and Therapeutic Interventions.
    Am J Pathol. 2026 Sep 25:S0002-9440(26)00282.
    PubMed         Abstract available

  2. LEE V, Chiang CC, Balogun O, Cornuet P, et al
    Wnt/beta-catenin reduces fibrosis and enhances hepatocyte reprogramming during cholestasis independent of Yap signaling.
    Am J Pathol. 2026 Sep 25:S0002-9440(26)00281.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  3. NAKATSUKASA Y, Hirano M, Yamada Y, Ohta S, et al
    MYCN reprograms postnatal cells toward embryonic-like transcriptional states and drives tumorigenesis.
    Biochem Biophys Res Commun. 2026;835:154488.
    PubMed         Abstract available


    BMC Gastroenterol

  4. RAVANSHAD S, Golestani MN, Ahadi M, Kabiri M, et al
    Evaluation of sleep quality and obstructive sleep apnea in non-alcoholic fatty liver disease: a cross-sectional study.
    BMC Gastroenterol. 2026;26:583.
    PubMed         Abstract available


    Gastroenterology

  5. MCCOY MS, Peiffer KH, Hahner JM, Praktiknjo M, et al
    When the Beat and the Bleed Compete: An Opportunity for INTERBLEED Subgroup Analysis in Patients With Liver Cirrhosis.
    Gastroenterology. 2026 Sep 21:S0016-5085(26)07256.
    PubMed        


    Gastrointest Endosc

  6. MARYA NB, Cosgrove N, Thiruvengadam NR, Nasser-Ghodsi N, et al
    American Society for Gastrointestinal Endoscopy guideline on management of esophageal and gastric varices in patients with cirrhosis.
    Gastrointest Endosc. 2026 Sep 25:S0016-5107(26)06936.
    PubMed        


    Gut

  7. ARMSTRONG MJ, Williams FR
    Rapid skeletal muscle loss in cirrhosis: the 'silent killer' within CT imaging.
    Gut. 2026 Sep 21:gutjnl-2026-340144. doi: 10.1136/gutjnl-2026-340144.
    PubMed        

  8. NIKITINA D, Suk KT, Torre A, Idilman R, et al
    Hospitalisation in cirrhosis is linked to distinct gut microbiome structural and functional profiles: a multinational metagenomic study.
    Gut. 2026 Sep 21:gutjnl-2026-339378. doi: 10.1136/gutjnl-2026-339378.
    PubMed         Abstract available

  9. ZHANG L, Chen C, Xu Y, Zhang Y, et al
    Integrative multi-omics landscape and diagnostic-therapeutic modelling of steatohepatitic hepatocellular carcinoma.
    Gut. 2026 Sep 22:gutjnl-2026-339304. doi: 10.1136/gutjnl-2026-339304.
    PubMed         Abstract available

  10. ZHANG J, Zhang M, Juramt D, Qi W, et al
    Single-nucleus transcriptomics refine the hepatic cellular context of the MASLD proteosurvival signature.
    Gut. 2026 Sep 22:gutjnl-2026-340378. doi: 10.1136/gutjnl-2026-340378.
    PubMed        

  11. TAO L, Liu N, Zhang W, Yang Z, et al
    Butyrylcholinesterase alleviates hepatic stellate cell activation via paracrine muscarinic signalling.
    Gut. 2026 Sep 23:gutjnl-2026-338932. doi: 10.1136/gutjnl-2026-338932.
    PubMed         Abstract available

  12. PEISELER M, Bengsch B
    Checkpoints in circulation: extracellular vesicles can predict immunotherapy response and resistance in hepatocellular carcinoma.
    Gut. 2026 Sep 24:gutjnl-2026-340093. doi: 10.1136/gutjnl-2026-340093.
    PubMed        

  13. YARCHOAN M, Llovet JM, Kelley RK, Finn R, et al
    Expert consensus on clinical trials for use of systemic therapy in patients with hepatocellular carcinoma undergoing surgical and locoregional therapies.
    Gut. 2026 Sep 24:gutjnl-2026-339505. doi: 10.1136/gutjnl-2026-339505.
    PubMed         Abstract available


    Hepatology

  14. FERNANDEZ-IGLESIAS A, Harris EN, Jalan-Sakrikar N, Kaur S, et al
    The hepatic sinusoid as a regulatory niche: From cellular specialization to precision hepatology.
    Hepatology. 2026 Sep 24. doi: 10.1097/HEP.0000000000001870.
    PubMed         Abstract available

  15. KE AW, Shi GM, Zhou J, Wu FZ, et al
    Erratum: Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma.
    Hepatology. 2026 Sep 24. doi: 10.1097/HEP.0000000000001848.
    PubMed        


    J Clin Oncol

  16. PEETERS SLJ, Uluc E, Rousian M, Groot Koerkamp B, et al
    Hepatic Arterial Infusion of Oxaliplatin After Liver Metastases Resection: Interpreting Efficacy and Toxicity.
    J Clin Oncol. 2026 Sep 24:JCO2601218. doi: 10.1200/JCO-26-01218.
    PubMed        

  17. GELLI M, Tanguy ML, Tselikas L, Malka D, et al
    Reply to: Hepatic Arterial Infusion of Oxaliplatin After Liver Metastases Resection: Interpreting Efficacy and Toxicity.
    J Clin Oncol. 2026 Sep 24:JCO2601748. doi: 10.1200/JCO-26-01748.
    PubMed        


    J Gastroenterol Hepatol

  18. LAU SY, Chan WK
    Letter to Editor-In Response to "The Malaysian Society of Gastroenterology and Hepatology Consensus Statements on Prevention and Early Detection of Hepatocellular Carcinoma in Malaysia".
    J Gastroenterol Hepatol. 2026 Sep 22. doi: 10.1111/jgh.70770.
    PubMed        

  19. BALOCH MSA, Rehman QSU, Saleem MZ
    Re: The Malaysian Society of Gastroenterology and Hepatology Consensus Statements on Prevention and Early Detection of Hepatocellular Carcinoma in Malaysia.
    J Gastroenterol Hepatol. 2026 Sep 21. doi: 10.1111/jgh.70771.
    PubMed        

  20. LAU G
    Translational Hepatology From Bedside to Global Policy: How Robust Clinical and Translational Research Reshapes Global Practice Guidelines and Patient Outcomes.
    J Gastroenterol Hepatol. 2026 Sep 21. doi: 10.1111/jgh.70742.
    PubMed         Abstract available


    J Hepatol

  21. VAN DER MERWE S, Korf H
    When containment fails: beta-adrenergic disruption of the gut-liver barrier in cirrhosis.
    J Hepatol. 2026 Sep 25:S0168-8278(26)02903-X. doi: 10.1016/j.jhep.2026.
    PubMed        

  22. CHENHAO J, Lu H, Yasong L, Jianhao Z, et al
    Restoration of aged liver regeneration by youthful systemic factors via LTbeta-driven hepatocyte reprogramming.
    J Hepatol. 2026 Sep 22:S0168-8278(26)02893-X. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available


    PLoS One

  23. METTANANDA C, Sivasumithran K, Ranaweera L, Madhubhashini A, et al
    Optimisation of metabolic dysfunction-associated steatotic liver disease (MASLD) screening algorithm for resource-poor settings using machine learning.
    PLoS One. 2026;21:e0352231.
    PubMed         Abstract available


    Transplantation

  24. FANG Y, Bouari S, van de Wetering J, den Hoed CM, et al
    Simultaneous Liver-kidney Versus Liver Transplantation Categorized by Pretransplant eGFR: Impact of the 2017 OPTN Policy.
    Transplantation. 2026 Jun 30. doi: 10.1097/TP.0000000000005776.
    PubMed         Abstract available

  25. FOZOUNI L, Cullaro G, Lai JC, Wadhwani SI, et al
    Metabolic Dysfunction-associated Liver Disease Associated With Poor Food Access and Geographic hot Spots Among Liver Transplant Candidates.
    Transplantation. 2026 Jun 25. doi: 10.1097/TP.0000000000005813.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum